•
Germany-based Fresenius Medical Care (FRA: FMEA) has released its financial report for the third quarter of 2024. The total revenues for the quarter reached EUR 4.76 billion, marking a year-on-year (YOY) decrease of 2% in constant exchange rate terms. The operating income saw a significant rise, increasing by 43% YOY…
•
Fresenius Medical Care AG has announced the official launch of its 6008 CARESystem hemodialysis filtration system in China, marking a significant advancement in the treatment options for patients with renal failure in the country. The 6008 CARESystem is comprised of a 6008 blood dialysis device and a complementary 6008 CARESet…